Syeda Marriam Bakhtiar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Syeda Marriam Bakhtiar has a total of 672 co-authors. Here are the top co-authors by number of shared publications:
- Amjad Ali
Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan
14 shared publications - Anderson Rodrigues Santos
Faculty of Computer Science, Federal University of Uberlândia, Uberlândia, Brazil
11 shared publications - Luis Carlos Guimarães
Laboratory of Genomics and Bioinformatics, Center of Genomics and Systems Biology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil
11 shared publications - Siomar de Castro Soares
Department of Microbiology, Immunology and Parasitology, Federal University of Triângulo Mineiro, Av. Frei Paulino, 30-Nossa Sra. da Abadia, Uberaba C.P. 38025-180, Minas Gerais, Brazil
11 shared publications - Syed Shah Hassan
Dr. Panjwani Center for Molecular Medicine & Drug Research, PCMD-ICCBS, University of Karachi, 75270, Pakistan; Department of Chemistry, Faculty of Natural Sciences, Islamia College Peshawar, KP 25120, Pakistan
11 shared publications Anderson Miyoshi
10 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Pakistan Agricultural Scientists Forum in The Journal of Animal and Plant Sciences
- Vol. 37 (1)
IDENTIFYING KLEBSIELLA PNEUMONIAE VACCINE CANDIDATES THROUGH PAN-GENOMICS
The rise of multidrug-resistant Klebsiella pneumoniae strains and the lack of licensed vaccines highlight the urgent need for effective immunization strategies. The pan-genome analysis was performed to find out the core proteins of K. pneumoniae using reverse vaccinology approaches. Selected core proteins based on subcellular localization, antigenicity, transmembrane features, and physicochemical properties help to identify potential vaccine candidates. Pan-genomic analysis of 154 complete K. pneumoniae proteomes revealed 15,319 protein families, of which 3,864 were classified as core proteins, reflecting the extensive genetic diversity of the species. Eight proteins involved in drug efflux, toxin export, small molecule diffusion, and bacterial adhesion (pilus assembly). Among these, three proteins involved in drug efflux and toxin export, four proteins involved in facilitating the passive diffusion of small molecules, one outer membrane protein involved in pilus assembly and bacterial adhesion. 3D structures of candidates were experimentally confirmed. The identified epitopes were predicted to be on the protein's surface and capable of MHC I and II binding, suggesting they could initiate an immune response. The identified epitopes suggest the feasibility of developing peptide-based vaccines. By integrating methods, we can create a peptide antigen library for broad or multiple K. pneumoniae vaccines. Keywords: Klebsiella pneumoniae. pan-genomics. reverse vaccinology. potential vaccine candidates. epitopes
- 19 October 2026
- Published by Pakistan Agricultural Scientists Forum in The Journal of Animal and Plant Sciences
- Vol. 37 (1)
Open AccessIDENTIFYING KLEBSIELLA PNEUMONIAE VACCINE CANDIDATES THROUGH PAN-GENOMICS
The rise of multidrug-resistant Klebsiella pneumoniae strains and the lack of licensed vaccines highlight the urgent need for effective immunization strategies. The pan-genome analysis was performed to find out the core proteins of K. pneumoniae using reverse vaccinology approaches. Selected core proteins based on subcellular localization, antigenicity, transmembrane features, and physicochemical properties help to identify potential vaccine candidates. Pan-genomic analysis of 154 complete K. pneumoniae proteomes revealed 15,319 protein families, of which 3,864 were classified as core proteins, reflecting the extensive genetic diversity of the species. Eight proteins involved in drug efflux, toxin export, small molecule diffusion, and bacterial adhesion (pilus assembly). Among these, three proteins involved in drug efflux and toxin export, four proteins involved in facilitating the passive diffusion of small molecules, one outer membrane protein involved in pilus assembly and bacterial adhesion. 3D structures of candidates were experimentally confirmed. The identified epitopes were predicted to be on the protein's surface and capable of MHC I and II binding, suggesting they could initiate an immune response. The identified epitopes suggest the feasibility of developing peptide-based vaccines. By integrating methods, we can create a peptide antigen library for broad or multiple K. pneumoniae vaccines. Keywords: Klebsiella pneumoniae. pan-genomics. reverse vaccinology. potential vaccine candidates. epitopes
- 28 April 2026
- Published by Taylor & Francis
- p. 282-308
Applications of Psychrophiles in Molecular Biology as an Innovative tool
- 28 April 2026
- Published by Taylor & Francis
- p. 282-308
Applications of Psychrophiles in Molecular Biology as an Innovative tool
- Top Cited PapersOpen Access
- 1 March 2026
- Published by Tsinghua University Press in iFungi
Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections
The epidemiological patterns of respiratory viruses are complex and highly diverse. Infections caused particularly by SARS-CoV-2 and influenza viruses are frequently followed by secondary mucormycosis, posing significant challenges to clinical management and public health. To address the challenges posed by secondary mucormycosis following respiratory viral infections, the Fungal Prevention and Control Team of the Center for Infectious Diseases at West China Hospital, Sichuan University, convened experts from relevant disciplines across the world, to develop the "Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections". This consensus aims to provide systematic guidance and optimize prevention strategies. It identifies high-risk populations for mucormycosis after respiratory viral infections and offers 12 preventive recommendations focusing on four areas: education and training, personal protection, early diagnosis and treatment, and infection control. The document also highlights key measures that remain controversial or insufficiently supported by evidence and outlines directions for future research to promote greater awareness and investigation of mucormycosis.
- 1 March 2026
- Published by Tsinghua University Press in iFungi
Top Cited PapersOpen AccessExpert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections
The epidemiological patterns of respiratory viruses are complex and highly diverse. Infections caused particularly by SARS-CoV-2 and influenza viruses are frequently followed by secondary mucormycosis, posing significant challenges to clinical management and public health. To address the challenges posed by secondary mucormycosis following respiratory viral infections, the Fungal Prevention and Control Team of the Center for Infectious Diseases at West China Hospital, Sichuan University, convened experts from relevant disciplines across the world, to develop the "Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections". This consensus aims to provide systematic guidance and optimize prevention strategies. It identifies high-risk populations for mucormycosis after respiratory viral infections and offers 12 preventive recommendations focusing on four areas: education and training, personal protection, early diagnosis and treatment, and infection control. The document also highlights key measures that remain controversial or insufficiently supported by evidence and outlines directions for future research to promote greater awareness and investigation of mucormycosis.
- Open Access
- 25 December 2025
- Published by University of Management and Technology in Current Trends in OMICS
- Vol. 5 (2) , 74-106
Pathogenic SNP Network Enhancing IL-2/JAK-STAT Signaling and T-Cell Responses in Celiac Disease
Celiac disease is an immune-mediated enteropathy caused by abnormal activation of T-cells triggered by dietary gluten. The underlying genetic processes that enhance the immune action remain poorly defined. The current paper focuses on studying four immune-regulatory single nucleotide polymorphisms (SNPs), namely rs11712165 (CD80), rs3184504 (SH2B3), rs243323 (SOCS1), and rs2298428 (UBE2L3), to investigate their possible combined effects on cytokine signaling dysregulation in celiac disease. With an integrative bioinformatics strategy that includes functional annotation tools, GTEx eQTL expression analysis, KEGG pathway mapping, and drug-gene interaction databases, the study was able to find a pattern of pathway-level disruption consistent with the IL-2/JAK-STAT axis. Increased CD80 expression correlated with stronger T-cell co-stimulation, augmented IL-2 secretion, and decreased SH2B3 expression inhibited the activity of inhibitory adapters and facilitated hyper-responsiveness to cytokine signaling. Simultaneous reductions in the expression of SOCS1 and UBE2L3 reduced the required negative responses and ubiquitin-mediated signal termination, permitting intracellular signal to be sustained beyond normal regulation. All these variant-induced changes culminated in the formation of a coordinated mechanistic pattern, whereby IL-2/JAK-STAT signaling was augmented and prolonged and T-cell activation and intestinal inflammation increased. The evidence above is consistent with recognized immunopathological characteristics of celiac disease, since overproduction of IL-2 signaling and impaired T-cell responses are factors leading to mucosal damage. The screening of drug interactions also indicated that there are a number of approved therapeutics against CD80 and JAK kinases and could provide more opportunities for pathway-specific interventions. In general, this paper illustrates the role of specific immune-regulatory SNPs interacting together to create a pro-inflammatory signaling space in celiac disease and also offers a genetically informed template to be used in future therapeutic endeavors.
- 25 December 2025
- Published by University of Management and Technology in Current Trends in OMICS
- Vol. 5 (2) , 74-106
Open AccessPathogenic SNP Network Enhancing IL-2/JAK-STAT Signaling and T-Cell Responses in Celiac Disease
Celiac disease is an immune-mediated enteropathy caused by abnormal activation of T-cells triggered by dietary gluten. The underlying genetic processes that enhance the immune action remain poorly defined. The current paper focuses on studying four immune-regulatory single nucleotide polymorphisms (SNPs), namely rs11712165 (CD80), rs3184504 (SH2B3), rs243323 (SOCS1), and rs2298428 (UBE2L3), to investigate their possible combined effects on cytokine signaling dysregulation in celiac disease. With an integrative bioinformatics strategy that includes functional annotation tools, GTEx eQTL expression analysis, KEGG pathway mapping, and drug-gene interaction databases, the study was able to find a pattern of pathway-level disruption consistent with the IL-2/JAK-STAT axis. Increased CD80 expression correlated with stronger T-cell co-stimulation, augmented IL-2 secretion, and decreased SH2B3 expression inhibited the activity of inhibitory adapters and facilitated hyper-responsiveness to cytokine signaling. Simultaneous reductions in the expression of SOCS1 and UBE2L3 reduced the required negative responses and ubiquitin-mediated signal termination, permitting intracellular signal to be sustained beyond normal regulation. All these variant-induced changes culminated in the formation of a coordinated mechanistic pattern, whereby IL-2/JAK-STAT signaling was augmented and prolonged and T-cell activation and intestinal inflammation increased. The evidence above is consistent with recognized immunopathological characteristics of celiac disease, since overproduction of IL-2 signaling and impaired T-cell responses are factors leading to mucosal damage. The screening of drug interactions also indicated that there are a number of approved therapeutics against CD80 and JAK kinases and could provide more opportunities for pathway-specific interventions. In general, this paper illustrates the role of specific immune-regulatory SNPs interacting together to create a pro-inflammatory signaling space in celiac disease and also offers a genetically informed template to be used in future therapeutic endeavors.
- Open Access
- 18 November 2025
- Published by National University of Sciences and Technology in NUST Journal of Natural Sciences
- Vol. 10 (3) , 1-15
A computational approach for correlational analysis of symptoms of major depressive disorder
Major Depressive Disorder (MDD) is a complicated mental illness that consists of wide range of correlated symptoms. According to DSM-V, it is characterized by pervasive low mood, loss of interest or pleasure in nearly all activities, and additional symptoms that can cause significant distress in social, occupational, and important areas of life. In this study, association rules, decision tree classification and agglomerative clustering are employed to classify MDD symptoms interconnection and their co-occurrence pattern. A combination of key symptoms occurrence, such as aggression with euphoric responses and overthinking with euphoria are identified through association rules that show highest lift values. Decision tree is employed to predict primary node which is mood swing as key predictor of MDD. Then, agglomerative clustering is used to split the dataset into three clusters based on expert diagnosis to identify the range of symptoms that overlap. In this study, computational approach is utilized to unravel the hidden pattern and overlapping of correlated symptoms that will help in improved diagnosis and better personalized treatment plans. This study highlighted the interrelationships of symptoms associated with MDD and their thorough examination for therapeutic approach. Future perspectives should focus on diverse datasets with extension and validation of findings that produce sustainable findings for clinical decision making. By the complex interplay of symptoms of MDD shows the contribution of this research towards advancement of evidence-based diagnostics, ultimately aim to improve clinical outcomes by intergradational symptomatic study.
- 18 November 2025
- Published by National University of Sciences and Technology in NUST Journal of Natural Sciences
- Vol. 10 (3) , 1-15
Open AccessA computational approach for correlational analysis of symptoms of major depressive disorder
Major Depressive Disorder (MDD) is a complicated mental illness that consists of wide range of correlated symptoms. According to DSM-V, it is characterized by pervasive low mood, loss of interest or pleasure in nearly all activities, and additional symptoms that can cause significant distress in social, occupational, and important areas of life. In this study, association rules, decision tree classification and agglomerative clustering are employed to classify MDD symptoms interconnection and their co-occurrence pattern. A combination of key symptoms occurrence, such as aggression with euphoric responses and overthinking with euphoria are identified through association rules that show highest lift values. Decision tree is employed to predict primary node which is mood swing as key predictor of MDD. Then, agglomerative clustering is used to split the dataset into three clusters based on expert diagnosis to identify the range of symptoms that overlap. In this study, computational approach is utilized to unravel the hidden pattern and overlapping of correlated symptoms that will help in improved diagnosis and better personalized treatment plans. This study highlighted the interrelationships of symptoms associated with MDD and their thorough examination for therapeutic approach. Future perspectives should focus on diverse datasets with extension and validation of findings that produce sustainable findings for clinical decision making. By the complex interplay of symptoms of MDD shows the contribution of this research towards advancement of evidence-based diagnostics, ultimately aim to improve clinical outcomes by intergradational symptomatic study.
- Open Access
- 5 June 2025
- Published by University of Management and Technology in Current Trends in OMICS
- Vol. 5 (1) , 40-66
Heart-related Clinical Biomarker Classification through Machine Learning Algorithms
Heart diseases continue to be a major global cause of morbidity and death. Their timely and accurate diagnosis for improved patient outcomes is direly needed. Clinical biomarkers for the timely diagnosis of heart diseases are known but underutilized due to the use of conventional analytical methods that lower the efficiency to handle large datasets. Furthermore, conventional methods also fail to incorporate demographic biomarkers such as age and hemodynamic biomarkers such as heart rate and diastolic blood pressure. This significantly influences heart diseases. Using cutting edge machine learning (ML) techniques including Lasso regularization, support vector machine (SVM), and gradient boosting (GB), this study investigated the importance of clinical biomarkers for heart disease prediction. Troponin and Creatinine Kinase - MB (CK-MB) were found to be the most significant predictors among the examined characteristics in every model, underscoring their crucial importance in the diagnosis of myocardial ischemia and damage. Diastolic blood pressure was also found to be an adequate predictor, highlighting its role in increasing cardiovascular risk because of autonomous dysfunction. While SVM and GB performed strongly in managing intricate data relationships, Lasso regularization successfully decreased feature redundancy. The results support the use of clinically applicable biomarkers in conjunction with machine learning to improve the accuracy of diagnosis and also opens the door to the personalized treatment of heart disease. Validating these findings in a variety of populations and adding more biomarkers for a thorough risk assessment should be the main goals of future studies.
- 5 June 2025
- Published by University of Management and Technology in Current Trends in OMICS
- Vol. 5 (1) , 40-66
Open AccessHeart-related Clinical Biomarker Classification through Machine Learning Algorithms
Heart diseases continue to be a major global cause of morbidity and death. Their timely and accurate diagnosis for improved patient outcomes is direly needed. Clinical biomarkers for the timely diagnosis of heart diseases are known but underutilized due to the use of conventional analytical methods that lower the efficiency to handle large datasets. Furthermore, conventional methods also fail to incorporate demographic biomarkers such as age and hemodynamic biomarkers such as heart rate and diastolic blood pressure. This significantly influences heart diseases. Using cutting edge machine learning (ML) techniques including Lasso regularization, support vector machine (SVM), and gradient boosting (GB), this study investigated the importance of clinical biomarkers for heart disease prediction. Troponin and Creatinine Kinase - MB (CK-MB) were found to be the most significant predictors among the examined characteristics in every model, underscoring their crucial importance in the diagnosis of myocardial ischemia and damage. Diastolic blood pressure was also found to be an adequate predictor, highlighting its role in increasing cardiovascular risk because of autonomous dysfunction. While SVM and GB performed strongly in managing intricate data relationships, Lasso regularization successfully decreased feature redundancy. The results support the use of clinically applicable biomarkers in conjunction with machine learning to improve the accuracy of diagnosis and also opens the door to the personalized treatment of heart disease. Validating these findings in a variety of populations and adding more biomarkers for a thorough risk assessment should be the main goals of future studies.
- 1 June 2025
- Published by Bentham Science Publishers Ltd. in Current Science, Engineering and Technology
- Vol. 5 (2) , 71-80
Remote Patient Monitoring: An E-Health Solution for Cardiac Patients
Cardiovascular disease (CVD) encompasses various heart conditions, such as arrhythmias, congenital heart diseases, and strokes. This review focuses on the remote monitoring of CVD patients by discussing the already available devices, the architecture of the CVD remote monitoring system, the challenges, and future perspectives. CVDs have become a major cause of morbidity and mortality globally, responsible for about 30% of all diseases. Risk factors for CVD include demographic characteristics, smoking, genetic factors, and lifestyle habits, such as obesity and physical inactivity. CVDs are no longer limited to developed countries, with 80% of CVDrelated mortality occurring in developing nations. Remote Patient Monitoring (RPM) technology allows healthcare providers to monitor patients using wearable and non-wearable devices, enabling efficient evaluation and consultation for better patient care. In the case of CVDs, timely intervention hinges on regular symptom monitoring and response to treatment, with Remote Patient Monitoring (RPM) emerging as a key approach. This method allows automatic recording of patient data through various devices, including invasive ones, such as pacemakers and implantable cardioverter defibrillators. Non-invasive devices aid in long-term self-management by monitoring and transmitting data to prevent emergencies and enhance prognosis. Patients with serious CVDs may have cardiac implantable electronic devices that provide continuous physiological information, which can be analyzed using machine learning algorithms to identify risks. RPM devices can reduce hospitalizations and costs by enabling preventive interventions and medication management, ultimately enhancing healthcare systems' ability to provide remote care for CVD patients. Despite the numerous applications of the digital health system, challenges hinder its implementation in developing countries. The main challenge lies in the absence of ICT infrastructure in rural areas, which hinders the effectiveness of healthcare systems, along with the difficulty in obtaining electronic devices and ensuring an uninterrupted power supply, both of which hamper the deployment of ICT services and the adoption of digital health systems by healthcare professionals and consumers. Overall, addressing these challenges requires human resource training, universal standards for RPM advancement, and a change in stakeholders' perceptions towards digital health technologies in underdeveloped nations.
- 1 June 2025
- Published by Bentham Science Publishers Ltd. in Current Science, Engineering and Technology
- Vol. 5 (2) , 71-80
Remote Patient Monitoring: An E-Health Solution for Cardiac Patients
Cardiovascular disease (CVD) encompasses various heart conditions, such as arrhythmias, congenital heart diseases, and strokes. This review focuses on the remote monitoring of CVD patients by discussing the already available devices, the architecture of the CVD remote monitoring system, the challenges, and future perspectives. CVDs have become a major cause of morbidity and mortality globally, responsible for about 30% of all diseases. Risk factors for CVD include demographic characteristics, smoking, genetic factors, and lifestyle habits, such as obesity and physical inactivity. CVDs are no longer limited to developed countries, with 80% of CVDrelated mortality occurring in developing nations. Remote Patient Monitoring (RPM) technology allows healthcare providers to monitor patients using wearable and non-wearable devices, enabling efficient evaluation and consultation for better patient care. In the case of CVDs, timely intervention hinges on regular symptom monitoring and response to treatment, with Remote Patient Monitoring (RPM) emerging as a key approach. This method allows automatic recording of patient data through various devices, including invasive ones, such as pacemakers and implantable cardioverter defibrillators. Non-invasive devices aid in long-term self-management by monitoring and transmitting data to prevent emergencies and enhance prognosis. Patients with serious CVDs may have cardiac implantable electronic devices that provide continuous physiological information, which can be analyzed using machine learning algorithms to identify risks. RPM devices can reduce hospitalizations and costs by enabling preventive interventions and medication management, ultimately enhancing healthcare systems' ability to provide remote care for CVD patients. Despite the numerous applications of the digital health system, challenges hinder its implementation in developing countries. The main challenge lies in the absence of ICT infrastructure in rural areas, which hinders the effectiveness of healthcare systems, along with the difficulty in obtaining electronic devices and ensuring an uninterrupted power supply, both of which hamper the deployment of ICT services and the adoption of digital health systems by healthcare professionals and consumers. Overall, addressing these challenges requires human resource training, universal standards for RPM advancement, and a change in stakeholders' perceptions towards digital health technologies in underdeveloped nations.
- 23 February 2025
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 44 (6) , 2888-2898
3-Dimensional structure prediction of C-terminal disrupted in schizophrenia 1: a suspected culprit of schizophrenia
Disrupted in schizophrenia 1 (DISC1) is a scaffolding protein involved in neurogenesis, synaptic development and cell signaling. It acts as a hub protein in different pathways by interacting with multiple proteins and regulates their function it is localized in various subcellular locations, including the nucleus, mitochondria, and cytoskeleton, this 854-amino acid protein comprises two segments: an N-terminal head and a C-terminal coiled-coil region. There are over two hundred interacting partners of DISC1. It is encoded by a gene present on chromosome 1q42.1 and its mutations lead to different genetic defects causing psychiatric conditions. A major genetic defect regarding DISC1 is a translocation event t(1;11) (q42.1;q14.3) which leads to a C-terminal truncated protein residues ∼1-598. This indicates the importance of DISC1 as a therapeutic target but the complete three-dimensional structure of DISC1 is yet not determined only partially reported in complexes or predicted structures are available. To understand the etiology, and pathophysiology of DISC1 the structure of the C-terminus needs to be determined as it participates in major molecular interactions. In this study, different approaches were used to determine the structure of C-terminus DISC1 where threading enabled us to develop a suitable model which was initially refined and later analyzed using quality assessment and validation tools. These findings are a key resource to understand the structural and functional properties of DISC1 and how they can help to identify new therapeutic targets for schizophrenia.
- 23 February 2025
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 44 (6) , 2888-2898
3-Dimensional structure prediction of C-terminal disrupted in schizophrenia 1: a suspected culprit of schizophrenia
Disrupted in schizophrenia 1 (DISC1) is a scaffolding protein involved in neurogenesis, synaptic development and cell signaling. It acts as a hub protein in different pathways by interacting with multiple proteins and regulates their function it is localized in various subcellular locations, including the nucleus, mitochondria, and cytoskeleton, this 854-amino acid protein comprises two segments: an N-terminal head and a C-terminal coiled-coil region. There are over two hundred interacting partners of DISC1. It is encoded by a gene present on chromosome 1q42.1 and its mutations lead to different genetic defects causing psychiatric conditions. A major genetic defect regarding DISC1 is a translocation event t(1;11) (q42.1;q14.3) which leads to a C-terminal truncated protein residues ∼1-598. This indicates the importance of DISC1 as a therapeutic target but the complete three-dimensional structure of DISC1 is yet not determined only partially reported in complexes or predicted structures are available. To understand the etiology, and pathophysiology of DISC1 the structure of the C-terminus needs to be determined as it participates in major molecular interactions. In this study, different approaches were used to determine the structure of C-terminus DISC1 where threading enabled us to develop a suitable model which was initially refined and later analyzed using quality assessment and validation tools. These findings are a key resource to understand the structural and functional properties of DISC1 and how they can help to identify new therapeutic targets for schizophrenia.
- 18 January 2025
- Published by Elsevier
Contributors
- 18 January 2025
- Published by Elsevier
- p. 279-296
The role of microorganisms in energy generation